Fig. 7From: Development and validation of a two glycolysis-related LncRNAs prognostic signature for glioma and in vitro analysesA Comparison of immune, stromal, and ESTIMATE scores between the high-risk group and low-risk group. B Volcano plots for the enrichment of immune cell types based on the normalized NES score between low-risk and high-risk patients from the GSEA. C The relationship between risk score and the expression of nine ICIs. D Comparison of TIDE scores between the high-risk group and the low-risk groupBack to article page